Astal Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	147.09	89.25	7.85	0.16	-0.17
Depreciation & Amortization	12.28	2.23	0.3	0.08	0.15
Change in Accounts Payable	453.45	-7.4	77.22	37.93	-0.62
Change in Other Net Operating Assets	-769.07	-105.5	-133.27	-50.81	0.26
Other Operating Activities	38.11	33.27	2.69	-1.73	-2.11
Operating Cash Flow	-176.99	-125.17	-55.79	-14.37	-2.49
Capital Expenditures	-13.93	-57.75	-59.17	-	-
Sale of Property, Plant & Equipment	-	-	-	-	0.25
Cash Acquisitions	-2.96	-	-	-	-
Investment in Securities	-7.73	-20.65	-	-	-
Net Decrease (Increase) in Loans Originated / Sold - Investing	-	-1	-2.05	13.24	-
Other Investing Activities	2.92	1.25	0.14	1.79	2.11
Investing Cash Flow	-21.7	-78.14	-61.08	15.03	2.36
Long-Term Debt Issued	-	3.17	3.3	-	-
Long-Term Debt Repaid	-16.57	-0.55	-0.17	-	-
Net Debt Issued (Repaid)	-16.57	2.62	3.12	-	-
Issuance of Common Stock	-	-	173.78	-	-
Other Financing Activities	42.37	30.29	-0.11	-	-
Financing Cash Flow	25.8	32.91	176.8	-	-
Net Cash Flow	-172.89	-170.41	59.92	0.66	-0.13
Free Cash Flow	-190.91	-182.92	-114.96	-14.37	-2.49
Free Cash Flow Margin	-7.72%	-28.74%	-48.61%	-39.83%	-118.03%
Free Cash Flow Per Share	-5.59	-16.48	-22.76	-3.62	-0.63
Cash Interest Paid	-	7.01	0.11	-	-
Cash Income Tax Paid	-	3.01	0.3	0.1	0